As in PRESTIGE-AF, some patients get no antithrombotic therapy, while the rest get a mix of aspirin, other antiplatelets, or left atrial appendage occlusion (LAAO). In that landscape, “this trial was ...

Objectives The aim of the present study was to investigate the association of high-sensitivity C-reactive protein (hs-CRP) with bleeding events among patients with acute coronary syndrome (ACS) ...

In CKD+HF, CKD+T2D and HF+T2D groups, prescription rates of renin-angiotensin system inhibitors (71%, 64.1% and 74.4%), beta-blockers (53.1%,36.2% and 55.1%), antiplatelets (56.2%, 45.2% and 54.4%) ...

The optimal management of severe traumatic brain injury (TBI) in the pediatric population has not been well studied. There are a limited number of research articles studying the management of TBI in ...

Your arteries are a key part of your heart and circulatory system. They carry oxygen-rich blood from the heart to organs and tissues around the body. But if the walls of the arteries become damaged by ...

Dual antiplatelet therapy (DAPT), comprising aspirin plus a P2Y12 inhibitor, is already recommended for people with ACS. While it reduces the risk of recurrent MI, it can increase bleeding risk in ...

The optimal threshold for defining prognostically relevant periprocedural myocardial injury (PMI) in patients with NSTEMI was found to be a post-PCI change in cardiac troponin I (cTnI) of >40%, along ...

Any of the following may be considered. Antiplatelet therapy with aspirin, aspirin plus dipyridamole, or Plavix (clopidogrel) is used to inhibit the formation of abnormal clots within the arteries.

Bleeding after starting anticoagulation for atrial fibrillation (AF) may be the first sign of malignancy, especially in elderly individuals. There are no recommendations to guide investigations for ...